{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:46:09Z","timestamp":1780695969141,"version":"3.54.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":905,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.seizure.2010.10.037","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T04:52:40Z","timestamp":1290574360000},"page":"126-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The impact of an educational intervention, the New GP Contract and NICE guidelines on anti-epilepsy therapeutic drug monitoring"],"prefix":"10.1016","volume":"20","author":[{"given":"I.","family":"Minshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2010.10.037_bib0005","first-page":"24","article-title":"Anticonvulsant therapy in a general practice population in Northern Ireland","volume":"34","author":"McCluggage","year":"1984","journal-title":"JRCGP"},{"key":"10.1016\/j.seizure.2010.10.037_bib0010","first-page":"731","article-title":"Audit of the care of patients with epilepsy in general practice","volume":"46","author":"Redhead","year":"1996","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.seizure.2010.10.037_bib0015","unstructured":"SIGN (Scottish Intercollegiate Guidelines Network). Guidelines for diagnosis and management of epilepsy in adults. Edinburgh, www.sign.ac.uk; 2003."},{"key":"10.1016\/j.seizure.2010.10.037_bib0020","unstructured":"National Institute of Clinical Excellence. The epilepsies: diagnosis and management of the epilepsies in adults in primary and secondary care. NICE, www.nice.org.uk\/pdf\/word\/CG020NICEguideline.doc (accessed September 2008); October 2004."},{"issue":"January","key":"10.1016\/j.seizure.2010.10.037_bib0025","article-title":"Therapeutic monitoring of antiepileptic drugs for epilepsy","volume":"1","author":"Tomson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2010.10.037_bib0030","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Anti-epileptic drugs\u2014best practice guidelines for therapeutic drug monitoring: a position paper by the sub-commission on therapeutic drug monitoring, ILAE Commission on therapeutic services","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.10.037_bib0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/qjmed\/hch057","article-title":"Inappropriate requests for antiepileptic blood levels","volume":"97","author":"Walters","year":"2004","journal-title":"Q J Med"},{"issue":"March (2)","key":"10.1016\/j.seizure.2010.10.037_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.seizure.2005.11.009","article-title":"The development of a city-wide epilepsy register","volume":"15","author":"Minshall","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2010.10.037_bib0045","unstructured":"New GMS Contract 2003. Investing in General Practice. The NHS Confederation; 2003."},{"issue":"April","key":"10.1016\/j.seizure.2010.10.037_bib0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.seizure.2007.08.002","article-title":"The impact of a city-wide audit with educational intervention on the care of patients with epilepsy","volume":"17","author":"Minshall","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2010.10.037_bib0055","unstructured":"Cheshire West PCT, QOF figures for epilepsy. Cheshire West PCT, 1829 Building, Countess of Chester Health Park, Liverpool Road, Chester; April 2009."},{"key":"10.1016\/j.seizure.2010.10.037_bib0060","unstructured":"Valproate. British National Formulary 57, 4.8.1; March 2009, p. 258."}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131110002682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131110002682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:39:36Z","timestamp":1761010776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131110002682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1059131110002682"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2010.10.037","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of an educational intervention, the New GP Contract and NICE guidelines on anti-epilepsy therapeutic drug monitoring","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2010.10.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}